Holen Sie sich die Stockscreener-App
2.28
3.17%
0.07
Schlusskurs vom Vortag:
$2.21
Offen:
$2.24
24-Stunden-Volumen:
729.45K
Relative Volume:
0.75
Marktkapitalisierung:
$157.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-77.22M
KGV:
-1.3004
EPS:
-1.7533
Netto-Cashflow:
$-77.27M
1W Leistung:
-11.97%
1M Leistung:
-28.30%
6M Leistung:
+31.79%
1J Leistung:
-55.12%
1-Tages-Spanne:
$2.225
$2.31
1-Wochen-Bereich:
$2.21
$2.65
52-Wochen-Spanne:
$1.31
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Firmenname
Pepgen Inc
Sektor
Branche
Telefon
703-456-8000
Adresse
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
2.28 | 179.38M | 0 | -77.22M | -77.27M | -1.7533 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Guggenheim | Buy |
| 2024-12-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-21 | Eingeleitet | H.C. Wainwright | Buy |
Pepgen Inc Aktie (PEPG) Neueste Nachrichten
PEPG Should I Buy - Intellectia AI
PepGen presents ongoing DM1 research findings at NMSG Meeting - Traders Union
PepGen Ltd (NYSE: PEPG) Share Price, PEPG Stock News, PEPG Share Price & Updates - kalkine.ca
PepGen Inc.Common Stock (Nasdaq:PEPG) Detailed Stock Data - The Chronicle-Journal
PepGen schedules oral and poster DM1 research at NMSG and WMS2026 conferences - Traders Union
PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PEPG Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Rise 4.35%Post-Announcement Reaction - vinanet.vn
PEPG Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 3.34% BounceDownward Estimate Revision - vinanet.vn
PepGen (PEPG) Edges Higher to $3.08 as Shares Hold Narrow Trading RangeMerger Arbitrage - vinanet.vn
Investor Alert: Deadline Approaching to Join PepGen Inc. (PEPG) Class ActionContact Levi & Korsinsky - The National Law Review
PepGen (PEPG) Q2 2026 Results: EPS Comes in Above Forecast on the Day; Post-Earnings: Shares Close 3.46% Higher in the Current UpdateReturn On Equity - vinanet.vn
PepGen (PEPG) Earnings Reading: EPS Beats Its Estimate on the Day; Latest Reaction: The Stock Records a 0.96% Increase in the Latest ReadingAnalyst Earnings Estimate - dars.gov.et
PepGen (PEPG) Financial Update: The Bottom-Line Figure Beats Its Comparison on the Day; Trading Move - vinanet.vn
PepGen (PEPG) Financial Update: The Bottom-Line Figure Beats Its Comparison on the Day; Trading Move: Shares Finish 0.98% Higher on the DayShare Repurchase Impact - dars.gov.et
GSA Capital Partners LLP Makes New Investment in PepGen, Inc. $PEPG - MarketBeat
PEPG Q2 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress ContinuesEBITDA Analysis - vinanet.vn
PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PepGen’s DM1 Bet Runs Into An FDA Hold And Dilution Fears - Finimize
PepGen Inc. (PEPG) Slips 1.17% to $2.94 as Biotech Stock Holds Above Key SupportUp Down Volume - vinanet.vn
Stifel Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $12 - Moomoo
PepGen Inc. (PEPG) Advances 2.76% to $2.98 as Biotech Stock Approaches Key ResistanceGrowth Stock Picks - dars.gov.et
PepGen (PEPG) Climbs 1.21% as Shares Approach Key $3.09 Resistance ZoneHigh Volume Stocks - vinanet.vn
Here's Why We're Watching PepGen's (NASDAQ:PEPG) Cash Burn Situation - Moomoo
PepGen identifies muscle weakness and myotonia as drivers of speech challenges in DM1 - Traders Union
HC Wainwright Has Positive Outlook of PepGen FY2027 Earnings - MarketBeat
Weekly Recap: 12.5/10 mg/kg dose escalation and Q4 2027 cash runway - TradingView
PepGen Inc. (PEPG) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 8, 2025 Deadline - The National Law Review
PepGen (NASDAQ:PEPG) Posts Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
PepGen Inc. Stock 12‑Month Price Target Cut to $10.19, Implies 323% Upside - TradingView
PepGen Inc (PEPG) Stock News Today - TradingKey
PepGenCash of $117.20 Mln as of June 30, 2 - Moomoo
PepGen Maintained at Buy as Analyst Cites Encouraging DM1 Safety/Efficacy Profile and Keeps $20 Price Target - TipRanks
H.C. Wainwright Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $20 - Moomoo
PepGen advances DM1 trial to highest dose cohort - Investing.com
PepGen Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Craig-Hallum Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $11 - moomoo.com
PepGen advances DM1 trial to highest dose cohort By Investing.com - Investing.com South Africa
PepGen Advances PGN-EDODM1 Trial and Strengthens Finances - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - biospace.com
PepGen Q2 net loss narrows as expenses fall - TradingView
PepGen Posts $17.8 Million Q2 Loss as Cash Reaches $117.2 Million - Quiver Quantitative
PepGen Inc. 1H 2026: Net loss $(35.6M), EPS $(0.51) — 10-Q Summary - TradingView
PGN-EDODM1 enters top dose group in new PepGen study - Traders Union
BRIEF-PepGen Q2 EPS USD -0.26 - TradingView
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - Yahoo Finance
PepGen Posts $17.8 Million Q2 Loss as Cash Reaches $117.2 Million | PEPG Stock News - Quiver Quantitative
Class Action Filed Against PepGen Inc. (PEPG) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
PepGen Inc. (PEPG) Climbs 2.66% to $1.93 as Traders Eye Key Resistance at $2.03Revenue Growth Stocks - vinanet.vn
PepGen Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Shareholders of PepGen Should Contact Faruqi & Faruqi Before August 11, 2025 to Discuss Your RightsPEPG - TMX Newsfile
Finanzdaten der Pepgen Inc-Aktie (PEPG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pepgen Inc-Aktie (PEPG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STRECK PAUL | EVP, Head of R&D |
Mar 04 '26 |
Sale |
6.23 |
1,879 |
11,709 |
76,226 |
| Donnelly Noel | Chief Financial Officer |
Mar 04 '26 |
Sale |
6.23 |
2,084 |
12,988 |
111,603 |
| McArthur James G | President and CEO |
Mar 04 '26 |
Sale |
6.23 |
5,275 |
32,876 |
296,326 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):